BEELINE HOLDINGS INC (BLNE) Fundamental Analysis & Valuation

NASDAQ:BLNE • US2778025005

Current stock price

2.37 USD
+0.15 (+6.76%)
Last:

This BLNE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BLNE Profitability Analysis

1.1 Basic Checks

  • In the past year BLNE has reported negative net income.
  • In the past year BLNE has reported a negative cash flow from operations.
  • BLNE had negative earnings in each of the past 5 years.
  • In the past 5 years BLNE always reported negative operating cash flow.
BLNE Yearly Net Income VS EBIT VS OCF VS FCFBLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • With a Return On Assets value of -45.78%, BLNE is not doing good in the industry: 87.00% of the companies in the same industry are doing better.
  • With a Return On Equity value of -55.90%, BLNE is not doing good in the industry: 82.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -45.78%
ROE -55.9%
ROIC N/A
ROA(3y)-45.89%
ROA(5y)-36.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLNE Yearly ROA, ROE, ROICBLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

  • BLNE's Gross Margin of 22.00% is on the low side compared to the rest of the industry. BLNE is outperformed by 60.00% of its industry peers.
  • BLNE's Gross Margin has improved in the last couple of years.
  • BLNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.05%
GM growth 5Y5.13%
BLNE Yearly Profit, Operating, Gross MarginsBLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BLNE Health Analysis

2.1 Basic Checks

  • BLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BLNE has been increased compared to 1 year ago.
  • Compared to 5 years ago, BLNE has more shares outstanding
  • BLNE has a better debt/assets ratio than last year.
BLNE Yearly Shares OutstandingBLNE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K
BLNE Yearly Total Debt VS Total AssetsBLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • BLNE has an Altman-Z score of 0.10. This is a bad value and indicates that BLNE is not financially healthy and even has some risk of bankruptcy.
  • BLNE has a Altman-Z score (0.10) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.16 indicates that BLNE is not too dependend on debt financing.
  • BLNE's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. BLNE outperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 0.1
ROIC/WACCN/A
WACC7.74%
BLNE Yearly LT Debt VS Equity VS FCFBLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • BLNE has a Current Ratio of 1.05. This is a normal value and indicates that BLNE is financially healthy and should not expect problems in meeting its short term obligations.
  • BLNE has a Current ratio (1.05) which is in line with its industry peers.
  • A Quick Ratio of 1.05 indicates that BLNE should not have too much problems paying its short term obligations.
  • The Quick ratio of BLNE (1.05) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
BLNE Yearly Current Assets VS Current LiabilitesBLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BLNE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 46.35% over the past year.
  • BLNE shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.31%.
  • BLNE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.16% yearly.
EPS 1Y (TTM)46.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.66%
Revenue 1Y (TTM)20.31%
Revenue growth 3Y-32.73%
Revenue growth 5Y-20.16%
Sales Q2Q%208.42%

3.2 Future

  • BLNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.64% yearly.
  • BLNE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 72.64% yearly.
EPS Next Y-66.92%
EPS Next 2Y39.8%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue Next Year-34.03%
Revenue Next 2Y50.76%
Revenue Next 3Y72.64%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BLNE Yearly Revenue VS EstimatesBLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
BLNE Yearly EPS VS EstimatesBLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 0 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

1

4. BLNE Valuation Analysis

4.1 Price/Earnings Ratio

  • BLNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLNE Price Earnings VS Forward Price EarningsBLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLNE Per share dataBLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BLNE's earnings are expected to grow with 29.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.8%
EPS Next 3Y29.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLNE Dividend Analysis

5.1 Amount

  • No dividends for BLNE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLNE Fundamentals: All Metrics, Ratios and Statistics

BEELINE HOLDINGS INC

NASDAQ:BLNE (3/25/2026, 8:12:37 PM)

2.37

+0.15 (+6.76%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-14
Earnings (Next)03-30
Inst Owners16.09%
Inst Owner Change74.69%
Ins Owners18.44%
Ins Owner Change58.68%
Market Cap68.59M
Revenue(TTM)7.69M
Net Income(TTM)-28.92M
Analysts85.71
Price Target4.59 (93.67%)
Short Float %6.26%
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.6%
Min EPS beat(2)-35.59%
Max EPS beat(2)22.39%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.99%
Min Revenue beat(2)-26.72%
Max Revenue beat(2)6.74%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-121.43%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.92
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 5.05
EV/EBITDA N/A
EPS(TTM)-23.9
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.27
BVpS1.79
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.78%
ROE -55.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22%
FCFM N/A
ROA(3y)-45.89%
ROA(5y)-36.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.05%
GM growth 5Y5.13%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 0.1
F-Score5
WACC7.74%
ROIC/WACCN/A
Cap/Depr(3y)62.29%
Cap/Depr(5y)46.27%
Cap/Sales(3y)7.25%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.66%
EPS Next Y-66.92%
EPS Next 2Y39.8%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue 1Y (TTM)20.31%
Revenue growth 3Y-32.73%
Revenue growth 5Y-20.16%
Sales Q2Q%208.42%
Revenue Next Year-34.03%
Revenue Next 2Y50.76%
Revenue Next 3Y72.64%
Revenue Next 5YN/A
EBIT growth 1Y-278.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-257.4%
EBIT Next 3Y111.41%
EBIT Next 5YN/A
FCF growth 1Y-364.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-379.02%
OCF growth 3YN/A
OCF growth 5YN/A

BEELINE HOLDINGS INC / BLNE Fundamental Analysis FAQ

What is the fundamental rating for BLNE stock?

ChartMill assigns a fundamental rating of 2 / 10 to BLNE.


What is the valuation status for BLNE stock?

ChartMill assigns a valuation rating of 1 / 10 to BEELINE HOLDINGS INC (BLNE). This can be considered as Overvalued.


Can you provide the profitability details for BEELINE HOLDINGS INC?

BEELINE HOLDINGS INC (BLNE) has a profitability rating of 1 / 10.


What is the financial health of BEELINE HOLDINGS INC (BLNE) stock?

The financial health rating of BEELINE HOLDINGS INC (BLNE) is 3 / 10.


Can you provide the expected EPS growth for BLNE stock?

The Earnings per Share (EPS) of BEELINE HOLDINGS INC (BLNE) is expected to decline by -66.92% in the next year.